To verify whether BM-MSCs had a therapeutic effect on renal fibrosis in vitro, we used exogenous cytokine TGF-β1 to stimulate mRTECs for 48h and to establish a fibrotic model in vitro. This evidence concerns the gene TGFB1 and renal fibrosis.